Link of serum esterase enzymes with cognitive impairment in diabetic patients

Cognitive impairment is one of the main complications of diabetes and patients with cognitive impairment are considered to be in an intermediate stage of decreased cognition with higher risk of developing dementia and Alzheimer's disease. This study aimed at evaluating serum activity of two est...

Full description

Saved in:
Bibliographic Details
Main Authors: Mahdavi P, Mokhtari S, Iranparvar M, Amani F, Mazani M, Mostafalou S
Format: Article
Language:en
Published: Penerbit Universiti Kebangsaan Malaysia 2024
Online Access:http://journalarticle.ukm.my/26285/1/Mh_11.pdf
http://journalarticle.ukm.my/26285/
https://medicineandhealthukm.com/node/187
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1852708757945974784
author Mahdavi P,
Mokhtari S,
Iranparvar M,
Amani F,
Mazani M,
Mostafalou S,
author_facet Mahdavi P,
Mokhtari S,
Iranparvar M,
Amani F,
Mazani M,
Mostafalou S,
author_sort Mahdavi P,
building Tun Sri Lanang Library
collection Institutional Repository
content_provider Universiti Kebangsaan Malaysia
content_source UKM Journal Article Repository
continent Asia
country Malaysia
description Cognitive impairment is one of the main complications of diabetes and patients with cognitive impairment are considered to be in an intermediate stage of decreased cognition with higher risk of developing dementia and Alzheimer's disease. This study aimed at evaluating serum activity of two esterase enzymes including cholinesterase and paraoxonase 1 (PON 1) in diabetic patients and association with cognitive performance and metabolic parameters. In this crosssectional study, 128 diabetic patients were enrolled. Cognitive performance was evaluated using the Wechsler Adult Intelligence Scale-Revised (WAIS-R). Body mass index, fasting blood glucose, fasting blood insulin, insulin resistance, serum cholinesterase and paraoxonase 1 activity were measured. Prevalence of cognitive impairment was found to be 77% in the study population. Serum cholinesterase activity was found to be higher in diabetic patients with cognitive impairment than the patients with normal cognitive performance (p < 0.04). Further, a negative correlation was found between cognitive performance and cholinesterase activity, albeit statistically non-significant. Alteration in the activity of cholinesterase enzyme was shown to be associated with cognitive impairment in diabetic patients and future studies are required to find the pathophysiological mechanisms of diabetic cognitive dysfunction.
format Article
id my-ukm.journal.26285
institution Universiti Kebangsaan Malaysia
language en
publishDate 2024
publisher Penerbit Universiti Kebangsaan Malaysia
record_format eprints
spelling my-ukm.journal.262852025-12-15T08:57:19Z http://journalarticle.ukm.my/26285/ Link of serum esterase enzymes with cognitive impairment in diabetic patients Mahdavi P, Mokhtari S, Iranparvar M, Amani F, Mazani M, Mostafalou S, Cognitive impairment is one of the main complications of diabetes and patients with cognitive impairment are considered to be in an intermediate stage of decreased cognition with higher risk of developing dementia and Alzheimer's disease. This study aimed at evaluating serum activity of two esterase enzymes including cholinesterase and paraoxonase 1 (PON 1) in diabetic patients and association with cognitive performance and metabolic parameters. In this crosssectional study, 128 diabetic patients were enrolled. Cognitive performance was evaluated using the Wechsler Adult Intelligence Scale-Revised (WAIS-R). Body mass index, fasting blood glucose, fasting blood insulin, insulin resistance, serum cholinesterase and paraoxonase 1 activity were measured. Prevalence of cognitive impairment was found to be 77% in the study population. Serum cholinesterase activity was found to be higher in diabetic patients with cognitive impairment than the patients with normal cognitive performance (p < 0.04). Further, a negative correlation was found between cognitive performance and cholinesterase activity, albeit statistically non-significant. Alteration in the activity of cholinesterase enzyme was shown to be associated with cognitive impairment in diabetic patients and future studies are required to find the pathophysiological mechanisms of diabetic cognitive dysfunction. Penerbit Universiti Kebangsaan Malaysia 2024 Article PeerReviewed application/pdf en http://journalarticle.ukm.my/26285/1/Mh_11.pdf Mahdavi P, and Mokhtari S, and Iranparvar M, and Amani F, and Mazani M, and Mostafalou S, (2024) Link of serum esterase enzymes with cognitive impairment in diabetic patients. Medicine & Health, 19 (1). pp. 161-172. ISSN 1823-2140 https://medicineandhealthukm.com/node/187
spellingShingle Mahdavi P,
Mokhtari S,
Iranparvar M,
Amani F,
Mazani M,
Mostafalou S,
Link of serum esterase enzymes with cognitive impairment in diabetic patients
title Link of serum esterase enzymes with cognitive impairment in diabetic patients
title_full Link of serum esterase enzymes with cognitive impairment in diabetic patients
title_fullStr Link of serum esterase enzymes with cognitive impairment in diabetic patients
title_full_unstemmed Link of serum esterase enzymes with cognitive impairment in diabetic patients
title_short Link of serum esterase enzymes with cognitive impairment in diabetic patients
title_sort link of serum esterase enzymes with cognitive impairment in diabetic patients
url http://journalarticle.ukm.my/26285/1/Mh_11.pdf
http://journalarticle.ukm.my/26285/
https://medicineandhealthukm.com/node/187
url_provider http://journalarticle.ukm.my/